Diagnosis and management of leptomeningeal disease secondary to grade IV astrocytic glioma

BMJ Case Rep. 2022 Sep 16;15(9):e250943. doi: 10.1136/bcr-2022-250943.

Abstract

A man in his mid-40s presented to hospital with confusion, headache and feeling generally unwell. He had had a total resection of a grade IV astrocytic glioma 1 year prior. Initial observations, blood tests and CT head scan were unremarkable for acute features to explain the patient's presentation. However, an MRI head scan on this admission demonstrated a clear communicating hydrocephalus with new abnormal leptomeningeal enhancement, consistent with leptomeningeal metastatic infiltration by glioma. Lumbar puncture cytology and biochemistry supported this interpretation. As a small district general hospital in rural Wales, we discuss the experience of diagnosis and coordination of specialist input from a multidisciplinary team. We share the challenges of managing leptomeningeal disease in the COVID-19 pandemic, in the context of the additional risks this presents with chemotherapy-induced immunosuppression.

Keywords: CNS cancer; Neurosurgery.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents*
  • Astrocytoma* / complications
  • Astrocytoma* / diagnostic imaging
  • Astrocytoma* / therapy
  • COVID-19 Testing
  • COVID-19*
  • Humans
  • Male
  • Meningeal Neoplasms* / complications
  • Meningeal Neoplasms* / diagnostic imaging
  • Meningeal Neoplasms* / therapy
  • Pandemics

Substances

  • Antineoplastic Agents